Clindamycin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Clindamycin. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Dryness | 105% |
| Erythema | 86% |
| Burning | 62% |
| Peeling | 61% |
| Burning/itching | 60% |
| Itching | 36% |
| Oiliness/oily skin | 26% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Clindamycin Phosphate Topical Solution, Clindamycin Phosphate Gel, and Clindamycin Phosphate Lotion are indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate. (See CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS. )
Source: FDA labeling via NIH DailyMed (set f93faee5…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.